RSMDF — RESMED INC
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 943819 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 1,431,406,000 | 890,979,000 | 499,810,000 | 398,732,000 | 8,784,285,000 | 1,660,513,000 | 2,292,374,000 |
| Dec 2025 | 1,422,808,000 | 878,724,000 | 497,595,000 | 392,593,000 | 8,503,370,000 | 1,417,069,000 | 2,182,491,000 |
| Sep 2025 | 1,335,582,000 | 820,820,000 | 462,347,000 | 348,536,000 | 8,308,352,000 | 1,383,848,000 | 2,187,088,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,889,964,000
Investing CF
$-295,261,000
Financing CF
$-907,752,000
CapEx
$-153,701,000
Dividends Paid
$-340,162,000
Buybacks
$-600,045,000
EPS Diluted TTM
$1.06
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$6,958,779,000
Inventory
$911,876,000
Receivables
$1,045,943,000
ST Investments
—
EBIT TTM
$1,916,323,000
Pretax Income TTM
$1,903,306,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,653,443,072
EBITDA
$2,095,774,976
Free Cash Flow
$939,248,256
Enterprise Value
$12,402,863,104
Total Cash
$1,469,234,048
Total Debt
$825,918,976
Shares Out
1,442,523,060
Trailing EPS
$1.04
Book Value
$11.41
ROE
24.3%
ROA
14.0%
Div Yield
1.17%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 5,653,443,000 | 1,908,460,000 | 1,523,293,000 | 8,965,950,000 | 2,380,557,000 | 6,585,393,000 | 1,805,829,000 |
| Jun 2025 | 5,146,327,000 | 1,685,363,000 | 1,400,723,000 | 8,174,391,000 | 2,206,532,000 | 5,967,859,000 | 1,751,588,000 |
| Jun 2024 | 4,685,297,000 | 1,384,121,000 | 1,020,951,000 | 6,872,394,000 | 2,008,351,000 | 4,864,043,000 | 1,401,260,000 |
| Jun 2023 | 4,222,993,000 | 1,151,997,000 | 897,556,000 | 6,751,708,000 | 2,621,805,000 | 4,129,903,000 | 693,299,000 |
TTM Snapshot
Revenues TTM
$4,977,432,000
NetIncome TTM
$1,331,066,000
OpCashFlow TTM
$0
Assets (Latest)
$8,174,391,000
Forward EPS
$0.41
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $145.17B | $405.18 | — |
| MDT | Medtronic plc | $113.38B | $88.64 | — |
| SYK | STRYKER CORP | $104.47B | $272.36 | — |
| MMM | 3M CO | $87.44B | $169.55 | — |
| BSX | BOSTON SCIENTIFIC CORP | $63.65B | $43.92 | — |
News headlines (Yahoo Finance, 1h cache)
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand
2026-09-21 20:02 · Yahoo
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
2026-09-19 08:18 · Yahoo
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
2026-09-15 20:07 · Yahoo
This Analyst Just Upgraded ResMed Stock. Here's Why.
2026-09-15 19:57 · Yahoo
Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)?
2026-09-15 17:11 · Yahoo
ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says
2026-09-15 15:00 · Yahoo
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
2026-09-15 14:10 · Yahoo
Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls
2026-09-15 13:35 · Yahoo
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More
2026-09-15 12:04 · Yahoo
Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest
2026-09-14 19:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.